Opus Genetics, Inc. Employee Benefits and Share-based Compensation
Opus Genetics, Inc. (IRD) reported Employee Benefits and Share-based Compensation of $100.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Notes › Compensation Related Costs
us-gaap:EmployeeBenefitsAndShareBasedCompensation · last filed 2026-03-12
- Opus Genetics, Inc. employee benefits and share-based compensation for the quarter ending 2025-12-31 was $0.00.
- Opus Genetics, Inc. employee benefits and share-based compensation for the quarter ending 2025-09-30 was $0.00.
- Opus Genetics, Inc. employee benefits and share-based compensation for the quarter ending 2025-06-30 was $0.00.
- Opus Genetics, Inc. employee benefits and share-based compensation for the quarter ending 2025-03-31 was $106.00K, a 56.73% decline year-over-year.
- Opus Genetics, Inc. employee benefits and share-based compensation for fiscal 2025 was $100.00K, a 50.00% decline from fiscal 2024.
- Opus Genetics, Inc. employee benefits and share-based compensation for fiscal 2024 was $200.00K, a 27.27% decline from fiscal 2023.
- Opus Genetics, Inc. employee benefits and share-based compensation for fiscal 2023 was $275.00K, a 78.57% increase from fiscal 2022.
- Opus Genetics, Inc. employee benefits and share-based compensation for fiscal 2022 was $154.00K, a 42.59% increase from fiscal 2021.
| Period end | Employee Benefits and Share-based Compensation 3 month | Employee Benefits and Share-based Compensation 3 month as first filed | Employee Benefits and Share-based Compensation 6 month | Employee Benefits and Share-based Compensation 9 month | Employee Benefits and Share-based Compensation 9 month as first filed | Employee Benefits and Share-based Compensation 12 month | Employee Benefits and Share-based Compensation 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $0.00 derived: sum of 2 quarters · filed 2026-03-12 | $0.00 derived: sum of 3 quarters · filed 2026-03-12 | $100.00K 10-K · filed 2026-03-12 | |||
| 2025-09-30 | $0.00 10-Q · filed 2025-11-12 | $0.00 derived: sum of 2 quarters · filed 2025-11-12 | $100.00K 10-Q · filed 2025-11-12 | $106.00K derived: sum of 4 quarters · filed 2026-03-12 | |||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $106.00K 10-Q · filed 2025-08-13 | $106.00K derived: sum of 3 quarters · filed 2026-03-12 | $106.00K derived: sum of 4 quarters · filed 2026-03-12 | |||
| 2025-03-31 | $106.00K 10-Q · filed 2025-05-15 | $106.00K derived: sum of 2 quarters · filed 2026-03-12 | $106.00K derived: sum of 3 quarters · filed 2026-03-12 | $106.00K derived: sum of 4 quarters · filed 2026-03-12 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $0.00 derived: sum of 2 quarters · filed 2026-03-12 | $0.00 derived: sum of 3 quarters · filed 2026-03-12 | $200.00K 10-K · filed 2026-03-12 | $245.00K 10-K · filed 2025-03-31 | ||
| 2024-09-30 | $0.00 10-Q · filed 2025-11-12 | $0.00 derived: sum of 2 quarters · filed 2025-11-12 | $200.00K 10-Q · filed 2025-11-12 | $245.00K 10-Q · filed 2024-11-12 | $245.00K derived: sum of 4 quarters · filed 2025-11-12 | ||
| 2024-06-30 | $0.00 10-Q · filed 2024-08-13 | $245.00K 10-Q · filed 2025-08-13 | $245.00K derived: sum of 3 quarters · filed 2025-05-15 | $245.00K derived: sum of 4 quarters · filed 2025-05-15 | |||
| 2024-03-31 | $245.00K 10-Q · filed 2025-05-15 | $245.00M 10-Q · filed 2024-05-10 | $245.00K derived: sum of 2 quarters · filed 2025-05-15 | $245.00K derived: sum of 3 quarters · filed 2025-05-15 | $273.00K derived: sum of 4 quarters · filed 2025-05-15 | ||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $0.00 derived: sum of 2 quarters · filed 2025-03-31 | $28.00K derived: sum of 3 quarters · filed 2025-03-31 | $275.00K 10-K · filed 2025-03-31 | |||
| 2023-09-30 | $0.00 10-Q · filed 2024-11-12 | $28.00K derived: sum of 2 quarters · filed 2024-11-12 | $275.00K 10-Q · filed 2024-11-12 | $247.03M derived: sum of 4 quarters · filed 2024-11-12 | |||
| 2023-06-30 | $28.00K 10-Q · filed 2024-08-13 | $275.00K 10-Q · filed 2024-08-13 | $247.03M derived: sum of 3 quarters · filed 2024-08-13 | $247.13M derived: sum of 4 quarters · filed 2024-08-13 | |||
| 2023-03-31 | $247.00M 10-Q · filed 2024-05-10 | $247.00K 10-Q · filed 2023-05-15 | $247.00M derived: sum of 2 quarters · filed 2024-05-10 | $247.10M derived: sum of 3 quarters · filed 2024-05-10 | $247.13M derived: sum of 4 quarters · filed 2024-05-10 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | $99.00K derived: sum of 2 quarters · filed 2024-03-08 | $126.00K derived: sum of 3 quarters · filed 2024-03-08 | $154.00K 10-K · filed 2024-03-08 | |||
| 2022-09-30 | $99.00K 10-Q · filed 2023-11-13 | $126.00K derived: sum of 2 quarters · filed 2023-11-13 | $154.00K 10-Q · filed 2023-11-13 | $180.00K derived: sum of 4 quarters · filed 2023-11-13 | |||
| 2022-06-30 | $27.00K 10-Q · filed 2023-08-11 | $55.00K 10-Q · filed 2023-08-11 | $81.00K derived: sum of 3 quarters · filed 2023-08-11 | $107.00K derived: sum of 4 quarters · filed 2023-08-11 | |||
| 2022-03-31 | $28.00K 10-Q · filed 2023-05-15 | $54.00K derived: sum of 2 quarters · filed 2023-05-15 | $80.00K derived: sum of 3 quarters · filed 2023-05-15 | $109.00K derived: sum of 4 quarters · filed 2023-05-15 | |||
| 2021-12-31 | $26.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $52.00K derived: sum of 2 quarters · filed 2023-03-30 | $81.00K derived: sum of 3 quarters · filed 2023-03-30 | $108.00K 10-K · filed 2023-03-30 | |||
| 2021-09-30 | $26.00K 10-Q · filed 2022-11-04 | $55.00K derived: sum of 2 quarters · filed 2022-11-04 | $82.00K 10-Q · filed 2022-11-04 | ||||
| 2021-06-30 | $29.00K 10-Q · filed 2022-08-12 | $55.00K 10-Q · filed 2022-08-12 | |||||
| 2021-03-31 | $26.00K 10-Q · filed 2022-05-13 | ||||||
| 2012-12-31 | $230.99K 10-K · filed 2013-03-22 | ||||||
| 2011-12-31 | $638.61K 10-K · filed 2013-03-22 | ||||||
| 2010-12-31 | $584.66K 10-K · filed 2013-03-22 | ||||||
| 2009-12-31 | $497.53K 10-K · filed 2013-03-22 | ||||||
| 2008-12-31 | $484.68K 10-K · filed 2013-03-22 | ||||||
| 2007-12-31 | $1.12M 10-K · filed 2013-03-22 | ||||||
| 2006-12-31 | $1.03M 10-K · filed 2013-03-22 | ||||||
| 2005-12-31 | $436.75K 10-K · filed 2013-03-22 | ||||||
| 2004-12-31 | $230.77K 10-K · filed 2013-03-22 | ||||||
| 2003-12-31 | $538.07K 10-K · filed 2013-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |